Literature DB >> 6112437

Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation.

V Bartele, C Cerletti, A Schiepatti, G di Minno, G de Gaetano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112437     DOI: 10.1016/s0140-6736(81)92224-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Inhibition by picotamide of thromboxane production in vitro and ex vivo.

Authors:  F Violi; A Ghiselli; L Iuliano; D Praticò; C Alessandri; F Balsano
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?

Authors:  Diana A Gorog; Joseph M Sweeny; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04-14       Impact factor: 32.419

3.  Inhibitory effect of econazole on the release of thromboxanes.

Authors:  S Jancar; C F Teixeira; W T de Lima; A Y Fujimura; P Sirois
Journal:  Agents Actions       Date:  1991-11

4.  Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.

Authors:  P Gresele; J Arnout; H Deckmyn; E Huybrechts; G Pieters; J Vermylen
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

5.  Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.

Authors:  G de Gaetano; V Bertelé
Journal:  Agents Actions       Date:  1984-01

6.  Human blood platelet behaviour after inhibition of thromboxane synthetase.

Authors:  S Heptinstall; S C Fox
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

7.  Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.

Authors:  G A FitzGerald; A R Brash; J A Oates; A K Pedersen
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

Review 8.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 9.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

10.  Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).

Authors:  M J Randall; R I Wilding
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.